Literature DB >> 3970037

Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland.

T Hakulinen, H Isomaki, P Knekt.   

Abstract

Two separate registries that cover the whole population of Finland have been linked in order to study the occurrence of cancer in patients with rheumatoid arthritis. The two registries involved were the Social Insurance Institution's Population Register, which collects information on medication for certain chronic diseases since 1967 including rheumatoid arthritis, and the Finnish Cancer Registry, which has data on all cancer patients in Finland since 1953. The 213,911 person-years' follow-up of 46,101 individuals with rheumatoid arthritis revealed 1,202 cases of cancer. The relative risk of cancer was 1.15 in males and 1.01 in females. The observed number of cases significantly exceeded that expected in Hodgkin's disease, non-Hodgkin's lymphomas, multiple myeloma, and leukemia. In general, the incidence of epithelial tumors was as expected. These findings were further supported by studying the occurrence of subsequent new primary cancers among patients with rheumatoid arthritis and cancer.

Entities:  

Mesh:

Year:  1985        PMID: 3970037     DOI: 10.1016/0002-9343(85)90242-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

1.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions.

Authors:  M M Doody; M S Linet; A G Glass; G D Friedman; L M Pottern; J D Boice; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

2.  Lymphadenopathy in a 20-year-old woman with mixed connective tissue disease.

Authors:  J M Zijlmans; P M Kluin; L J Schultze Kool; R Bieger
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 3.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

4.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

Review 5.  Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.

Authors:  Meenakshi Bewtra; James D Lewis
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

6.  Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.

Authors:  O Landgren; B I Graubard; J A Katzmann; R A Kyle; I Ahmadizadeh; R Clark; S K Kumar; A Dispenzieri; A J Greenberg; T M Therneau; L J Melton; N Caporaso; N Korde; M Roschewski; R Costello; G M McQuillan; S V Rajkumar
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

7.  Lupus/Sjögren's autoantibody specificities in sera with paraproteins.

Authors:  A L Sestak; J B Harley; S Yoshida; M Reichlin
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 8.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

9.  Risk of cancer among rheumatoid arthritis patients in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2009-01-28       Impact factor: 2.506

10.  Immune surveillance and lymphoid malignancy in immunocompromised host.

Authors:  Patrick L Stevens; Nishitha M Reddy
Journal:  Am J Blood Res       Date:  2013-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.